We are live on ! Find out more
NTC

NF Trinity Capital Portfolio holdings

AUM $626M
1-Year Est. Return 3.16%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+3.16%
3 Year Est. Return
+49.61%
5 Year Est. Return
10 Year Est. Return
AUM
$705M
AUM Growth
-$33.5M
Cap. Flow
-$127M
Cap. Flow %
-18%
Top 10 Hldgs %
65.12%
Holding
53
New
9
Increased
1
Reduced
9
Closed
5

Sector Composition

1 Communication Services 25.87%
2 Consumer Discretionary 15.73%
3 Healthcare 12.78%
4 Technology 10.72%
5 Financials 10.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLNX
26
DELISTED
Xilinx Inc
XLNX
$4.89M 0.69%
+76,000
New +$4.8M
NBIX icon
27
Neurocrine Biosciences
NBIX
$17.2B
$4.84M 0.69%
105,202
-78,000
-43% -$3.78M
ARAV
28
DELISTED
Aravive, Inc. Common Stock
ARAV
$4.27M 0.61%
40,816
TAL icon
29
TAL Education Group
TAL
$5.68B
$4.15M 0.59%
+203,604
New +$4M
CRM icon
30
Salesforce
CRM
$140B
$3.9M 0.55%
45,000
VTRS icon
31
Viatris
VTRS
$20.1B
$3.88M 0.55%
100,000
SLB icon
32
SLB Ltd
SLB
$70.3B
$3.65M 0.52%
55,500
MSCC
33
DELISTED
Microsemi Corp
MSCC
$3.43M 0.49%
+73,240
New +$3.58M
TMUS icon
34
T-Mobile US
TMUS
$208B
$3.21M 0.46%
+53,000
New +$3.45M
MOMO
35
Hello Group
MOMO
$886M
$2.77M 0.39%
+75,000
New +$2.88M
ZAYO
36
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$2.41M 0.34%
78,080
VNET
37
VNET Group
VNET
$2.1B
$2.23M 0.32%
443,800
TEVA icon
38
Teva Pharmaceuticals
TEVA
$37.3B
$1.76M 0.25%
53,000
FLNT
39
Fluent
FLNT
$111M
$984K 0.14%
32,467
VIPS icon
40
Vipshop
VIPS
$6.96B
$475K 0.07%
+45,000
New +$588K
ONC
41
BeOne Medicines Ltd
ONC
$32.4B
$454K 0.06%
+10,082
New +$397K
NXPI icon
42
CALL
NXP Semiconductors
NXPI
$67.3B
$300K 0.04%
150,000
ABBV icon
43
AbbVie
ABBV
$450B
-48,000
Closed -$3.13M
EW icon
44
Edwards Lifesciences
EW
$49.4B
-168,243
Closed -$5.28M
PANW icon
45
Palo Alto Networks
PANW
$292B
-210,000
Closed -$3.94M
PYPL icon
46
PayPal
PYPL
$49.9B
-125,900
Closed -$5.42M
SGEN
47
DELISTED
Seagen Inc. Common Stock
SGEN
-74,596
Closed -$4.69M

Similar funds

NF Trinity Capital's Q2 2017 Portfolio in Review

As of Q2 2017, NF Trinity Capital held 53 positions worth $705M, down 4.5% from $739M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

NF Trinity Capital withdrew a net $127M in Q2 2017, closing 5 positions and reducing 9 holdings. Its most notable exit was PayPal, an estimated $5.42M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, NF Trinity Capital opened a new position in Acadia Pharmaceuticals worth $5.72M.

  • NF Trinity Capital's largest Q2 2017 buy was Acadia Pharmaceuticals: 205,000 shares worth $5.72M.
  • NF Trinity Capital added most to BioMarin Pharmaceuticals in Q2 2017, an estimated $3.09M increase.
  • NF Trinity Capital's biggest Q2 2017 reduction was iShares Biotechnology ETF, cutting an estimated $13.6M.
  • NF Trinity Capital fully exited PayPal in Q2 2017, selling an estimated $5.42M.
  • NF Trinity Capital's ten largest holdings make up 65% of its $705M portfolio in Q2 2017.
  • NF Trinity Capital opened 9 new positions and closed 5 in Q2 2017.
  • NF Trinity Capital's portfolio value fell 4.5% quarter-over-quarter to $705M.

Based on NF Trinity Capital's 13F filing for Q2 2017, filed 8 Aug 2017.